Filters and Topics
Search Results
Upadacitinib: Uses, Side Effects & Dosage
Healio
https://www.healio.com › clinical-guidance › drugs › u...
Healio
https://www.healio.com › clinical-guidance › drugs › u...
Aug 20, 2025 — Upadacitinib is used to treat certain types of arthritis (such as psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, ...
upadacitinib (Rx)
Medscape Reference
https://reference.medscape.com › drug › rinvoq-upadac...
Medscape Reference
https://reference.medscape.com › drug › rinvoq-upadac...
Indicated for moderately to severely active rheumatoid arthritis (RA) in adults who have had an inadequate response or intolerance to ≥1 tumor necrosis factor ...See more
Upadacitinib | Jak1
R&D Systems
https://www.rndsystems.com › JAK Kinase Inhibitors
R&D Systems
https://www.rndsystems.com › JAK Kinase Inhibitors
Upadacitinib is a potent and selective JAK1 inhibitor (IC 50 = 47 nM). In a cellular assay, Upadacitinib shows selectivity for JAK1 over JAK2, JAK3 and TYK2.See more
Upadacitinib | CAS NO.:1310726-60-3
GlpBio
https://www.glpbio.com › upadacitinib
GlpBio
https://www.glpbio.com › upadacitinib
Upadacitinib is a highly potent, orally administered, and reversible selective Janus kinase 1 (JAK1) inhibitor with an IC50 value of 0.043μM.See more
Free 365-day returns
Upadacitinib - BAD Patient Hub
BAD Patient Hub
https://www.skinhealthinfo.org.uk › condition › upadac...
BAD Patient Hub
https://www.skinhealthinfo.org.uk › condition › upadac...
Upadacitinib is a type of drug known as a Janus kinase (JAK) inhibitor. It helps with conditions like atopic eczema (or atopic dermatitis)See more
MEDICATION GUIDE RINVOQ® (RIN-VOKE) (upadacitinib ...
RxAbbVie
https://www.rxabbvie.com › pdf › rinvoq_medg...
RxAbbVie
https://www.rxabbvie.com › pdf › rinvoq_medg...
PDF
RINVOQ/RINVOQ LQ is a medicine that affects your immune system. RINVOQ/RINVOQ LQ can lower the ability of your immune system to fight infections. Some people ...See more
Upadacitinib 1310726-60-3 - Sinoway
china-sinoway.com
https://www.china-sinoway.com › API
china-sinoway.com
https://www.china-sinoway.com › API
Upadatinib is primarily indicated for patients with refractory, moderate-to-severe atopic dermatitis in adults and adolescents 12 years of age and older.
FAQ – Rinvoq (Upadacitinib)
National Eczema Association
https://nationaleczema.org › faq-upadacitinib
National Eczema Association
https://nationaleczema.org › faq-upadacitinib
Rinvoq (upadacitinib) is an oral JAK1 inhibitor approved by the FDA for adults and adolescents aged 12+ years with moderate to severe atopic dermatitis.See more
Rinvoq, INN-Upadacitinib; - European Medicines Agency (EMA)
European Medicines Agency
https://www.ema.europa.eu › product-information
European Medicines Agency
https://www.ema.europa.eu › product-information
PDF
Dec 16, 2019 — RINVOQ is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or ...See more
Upadacitinib - StatPearls - NCBI Bookshelf - NIH
National Institutes of Health (.gov)
https://www.ncbi.nlm.nih.gov › books › NBK572088
National Institutes of Health (.gov)
https://www.ncbi.nlm.nih.gov › books › NBK572088
by IS Padda2024Cited by 28 — The recommended daily dosage is 15 mg orally as monotherapy. The medication can be taken with or without food and should be consumed as a whole ...See more